Comparison between Cryogenic OGS IPO and Netanalytiks Technologies IPO.
Cryogenic OGS IPO is a SME Fixed Price IPO proposed to list at BSE SME while Netanalytiks Technologies IPO is a SME Fixed Price proposed to list at BSE SME.
| Cryogenic OGS IPO | Netanalytiks Technologies IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Fixed Price |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Beeline Capital Advisors Pvt.Ltd. | Finshore Management Services Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | Integrated Registry Management Services Pvt.Ltd. |
| Market Maker | Spread X Securities Pvt.Ltd. | Black Fox Financial Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Cryogenic OGS IPO is up to ₹16.88 Cr whereas the issue size of the Netanalytiks Technologies IPO is up to ₹11.23 Cr. The final issue price of Cryogenic OGS IPO is ₹47.00 per share and of Netanalytiks Technologies IPO is ₹100.00 per share.
| Cryogenic OGS IPO | Netanalytiks Technologies IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹44.00 per share | |
| Issue Price (Upper) | ₹47.00 per share | |
| Issue Price (Final) | ₹47.00 per share | ₹100.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 3000 shares | 1200 shares |
| Fresh Issue Size | 35,91,000 shares | 11,23,200 shares |
| Fresh Issue Size (Amount) | up to ₹16.88 Cr | up to ₹11.23 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 35,91,000 shares | 11,23,200 shares |
| Issue Size Total (Amount) | up to ₹16.88 Cr | up to ₹11.23 Cr |
Cryogenic OGS IPO opens on Jul 03, 2025, while Netanalytiks Technologies IPO opens on . The closing date of Cryogenic OGS IPO and Netanalytiks Technologies IPO is Jul 07, 2025, and , respectively.
| Cryogenic OGS IPO | Netanalytiks Technologies IPO | |
|---|---|---|
| Anchor Bid Date | Jul 02, 2025 | |
| Issue Open | Jul 03, 2025 | |
| Issue Close | Jul 07, 2025 | |
| Basis Of Allotment (Tentative) | Jul 08, 2025 | |
| Initiation of Refunds (Tentative) | Jul 09, 2025 | |
| Credit of Share (Tentative) | Jul 09, 2025 | |
| Listing date (Tentative) | Jul 10, 2025 | |
| Anchor Lockin End date 1 | Aug 06, 2025 | |
| Anchor Lockin End date 2 | Oct 05, 2025 |
Cryogenic OGS IPO P/E ratio is 8.06, as compared to Netanalytiks Technologies IPO P/E ratio of .
| Cryogenic OGS IPO | Netanalytiks Technologies IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Cryogenic OGS Ltd.'s revenue increased by 32% and profit after tax (PAT) rose by 15% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Standalone)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 84.1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.52 | 59.6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 8.06 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹67.12 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 23.62 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 28.93 | 58.13 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.04 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹5.83 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 21.12 | 46.03 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Cryogenic OGS IPO Retail Individual Investors (RII) are offered 12,60,000 shares while in Netanalytiks Technologies IPO retail investors are offered 12,60,000 shares. Qualified Institutional Buyers (QIB) are offered 7,17,000 shares in Cryogenic OGS IPO and in Netanalytiks Technologies IPO.
| Cryogenic OGS IPO | Netanalytiks Technologies IPO | |
|---|---|---|
| Anchor Investor Reservation | 10,74,000 shares | |
| Market Maker Reservation | 1,89,000 shares | 56,400 shares |
| QIB | 7,17,000 shares | |
| NII | 5,40,000 shares | |
| RII | 12,60,000 shares | |
| Employee | ||
| Others | ||
| Total | 35,91,000 shares |
Cryogenic OGS IPO subscribed 694.90x in total, whereas Netanalytiks Technologies IPO subscribed .
| Cryogenic OGS IPO | Netanalytiks Technologies IPO | |
|---|---|---|
| QIB (times) | 209.59x | |
| NII (times) | 1,155.38x | |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 773.70x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 694.90x |
